Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine)

Clinical Toxicology

Volumn 46, Issue 9, 2008, Pages 823-826

  Fazelat, Joyia ^a   Teperman, Sheldon H ^a   Touger, Michael ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Coagulopathy; Fab (ovine); Hemorrhage; Rattlesnake

Indexed keywords

CROTALIDAE POLYVALENT IMMUNE FAB; SNAKE VENOM; SNAKE VENOM ANTISERUM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLEEDING; CASE REPORT; ENVENOMATION; HUMAN; MALE; RECURRENT DISEASE; SNAKEBITE; THROMBOCYTOPENIA;

ADULT; ANIMALS; ANTIVENINS; CROTALID VENOMS; CROTALUS; DRUG ADMINISTRATION SCHEDULE; HEMATOCRIT; HEMATOMA; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MALE; RECURRENCE; SNAKE BITES; THROMBOCYTOPENIA;

CROTALUS ATROX; OVIS;

EID: 55949128526     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701753849     Document Type: Article

References (13)

1. Chippaux JP. Snake bites: Appraisal of the global situation. Bull World Health Organ 1998; 76(5):515-524.
2. Gold BS, Dart RC, Barrish RA. Bites and Venomous Snakes. NEJM 2002; 347:347-356.
3. White, J. Snake venoms and coagulopathy. Toxicon 2005; 45:951-967.
4. Crotalidae Polyvalent Immune Fab (Ovine). AHFS Drug Information® (2006).
5. Boyer LV, Seifert SA, Clark RF, McNally JT, Williams SR, Nordt SP, Walter FG, Dart RC. Recurrent and persistent coagulopathy following pit viper envenomation. Arch Intern Med 1999; 159:706-710.
6. Antivenin (Crotalidae) Polyvalent. Mosby's Drug Consult™ - 16th ed. (2006).
7. Dart RC, McNally J. Efficacy, safety, and use of snake antivenoms in the United States. Ann Emerg Med. 2001; 37:181-8.
8. Seifert SA, Boyer LV. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies. Ann Emerg Med 2001; 37:189-195.
9. Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with Crotaline Fab antivenom. Ann Emerg Med 2001; 37:196-210.
10. Seifert SA, Boyer LV, Dart RC, Porter RS, Sjostrom L. Relationship of Venom Effects to Venom Antigen and Antivenom Serum Concentrations in a Patient with Crotalus atrox Envenomation Treated with Fab Antivenom. Ann Emerg Med 1997; 30:49-53.
11. Bogdan GM, Dart RC, Falbo SC, McNally J, Spaite D. Recurrent coagulopathy after antivenom treatment of crotalid snakebite. South Med J 2000; 93:562-566.
12. Dart RC, Seifert SA, Boyer LV, Clark RC, Hall E, McKinney P, McNally J, Kitchems CS, Curry SC, Bogdan GM, Ward SB, Porter RS. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001; 161:2030-6.
13. Dart RC, Seifert SA, Carroll L, Clark RF, Hall E, Boyer-Hassen LV, Curry SC, Kitchens CS, Garcia RA. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997; 30:33-9.